BMO Capital Upgrades Pacira Pharmaceuticals (PCRX) to Market Perform

October 27, 2016 7:11 AM EDT
Get Alerts PCRX Hot Sheet
Price: $40.10 -2.08%

Rating Summary:
    11 Buy, 6 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade PCRX Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

BMO Capital upgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Underperform to Market Perform.

For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.

Shares of Pacira Pharmaceuticals closed at $35.50 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

BMO Capital

Add Your Comment